Smart drugs

  • Talking Point
  • Audio archive

Cognitive enhancing drugs are used to treat neuropsychiatric disorders such as Alzheimer's disease, schizophrenia and attention deficit hyperactivity disorder. These drugs improve the quality of life and wellbeing for patients and their families.

Professor Barbara Sahakian will discuss how cognitive enhancement has ethical implications for society, particularly in regard to the increasing use of cognitive enhancing drugs in school-age children, and in young adults and academic staff at University. Therefore, it is important to consider the potential harms of these drugs (such as substance abuse, unknown effects on the developing brain or coercion at school or work).

Nevertheless, advances in gene studies to predict responses to drugs are rapidly developing, and we may be able to gain maximum benefits with minimum harms to the individual and society as a whole. This talk aims to explore the potential risk weighed against the great benefits in the use of safe and effective cognitive enhancing drugs to many sectors of society, including the ageing population and people with neuropsychiatric disorders and brain injury.

Tickets cost £8 standard, £6 concessions, £4 Ri Members.

Make a night of it! Come for a cocktail or something delicious, modern and British to eat in the bar. ‘Time & Space' at the Ri has the perfect atmosphere for a casual night out.  Time & Space: cafe, bar and restaurant

Listen to the audio archive of this event:

http://ri.content.s3.amazonaws.com/podcasts/2010/February/22 SmartDrugs.mp3

Keywords

  1. 17068 articles are tagged with brain 
  2. 2501 articles are tagged with cognitive 
  3. 5072 articles are tagged with ethics 
  4. 8734 articles are tagged with neuroscience